A diagnostic and clinical innovation pipeline for New Zealand & Oceania.
Translyx Limited introduces globally validated diagnostic and clinical products to New Zealand healthcare — across AMR, sepsis, point-of-care testing, oncology, endocrine, cardiac, and precision medicine — alongside authorised digital pathology AI and Privexa-built governed AI.
Authorised partner solution
Aiforia Digital Pathology AI
Translyx is an authorised non-exclusive business partner of Aiforia Technologies Plc in New Zealand, representing Aiforia Clinical Suites and Aiforia Create Platform. Aiforia strengthens the oncology biomarkers, digital pathology, and precision medicine areas of this pipeline.
Antibacterial Resistance
Antibacterial resistance remains an urgent public health concern even in New Zealand. While overall resistance rates here are lower than in some neighbouring regions, resistant strains are increasingly detected.
Learn more
Sepsis
Sepsis is a leading cause of serious illness and death, and it places a heavy burden on healthcare systems in New Zealand and internationally. In Aotearoa, sepsis is responsible for tens of thousands of infections annually.
Learn more
Oncology Biomarkers
Cancer remains a significant health challenge in New Zealand, with more than 30,000 people expected to be diagnosed each year in 2025. Accurate and timely biomarker testing is a cornerstone of modern oncology.
Learn more
Cardiac Biomarkers
Cardiovascular disease remains one of the leading causes of death and health burden in New Zealand. Cardiac biomarkers play a central role in diagnosing acute coronary syndromes and stratifying risk.
Learn more
Endocrine Biomarkers
Endocrine disorders such as diabetes, thyroid disease, and metabolic syndromes are highly prevalent in New Zealand. Accurate measurement of endocrine biomarkers is essential for diagnosing disease and guiding clinical interventions.
Learn more
Point of Care Testing
Point of care testing (POCT) is increasingly recognised as a vital part of modern healthcare delivery. POCT helps reduce turnaround times by providing diagnostic results near the patient.
Learn moreDiscuss diagnostic technology for your organisation.
Contact Translyx to discuss how advanced diagnostics, digital pathology AI, and governed clinical AI solutions fit your healthcare or research priorities.